REGENERON PHARMACEUTICALS (REGN) — institutional ownership
1,476 funds reported holding REGENERON PHARMACEUTICALS in their latest 13F filings, worth $67.9B in total (CUSIP 75886F107).
Largest holders
- VANGUARD GROUP INC — $7.00B
- BlackRock, Inc. (BLK) — $5.68B
- VANGUARD CAPITAL MANAGEMENT LLC — $4.13B
- DODGE & COX — $3.04B
- STATE STREET CORP (STT, STT-PG) — $3.01B
- Invesco Ltd. (IVZ) — $2.46B
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $2.38B
- VANGUARD PORTFOLIO MANAGEMENT LLC — $1.98B
- FRANKLIN RESOURCES INC (BEN) — $1.73B
- GEODE CAPITAL MANAGEMENT, LLC — $1.63B
Famous investors holding it
- Two Sigma portfolio (Two Sigma Investments)
- Ken Griffin portfolio (Citadel Advisors)
- Izzy Englander portfolio (Millennium Management)
- Mason Hawkins portfolio (Southeastern Asset Management)
- Renaissance Technologies portfolio (Renaissance Technologies)
- Ray Dalio portfolio (Bridgewater Associates)
- D. E. Shaw portfolio (D. E. Shaw & Co.)